Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivotal study of oral BC1036 for persistent cough
2011-004589-14Phase 3Completed
- Sponsor
- RESPICOPEA HOLDINGS LIMITED
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic cough and cough comparing BC1036 with Placebo (2 arms). Primary endpoint: Cough-related quality of life (LCQ) at Day 14. Started Apr 2012; status: completed.
02
Drugs
theobromine
03
Conditions
chronic coughcough
Beyond the preview
Go deeper on 2011-004589-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004589-14.